Akinari Morinaga

449 total citations
25 papers, 312 citations indexed

About

Akinari Morinaga is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Akinari Morinaga has authored 25 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Hepatology and 11 papers in Oncology. Recurrent topics in Akinari Morinaga's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Akinari Morinaga is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Akinari Morinaga collaborates with scholars based in Japan. Akinari Morinaga's co-authors include Tomoharu Yoshizumi, Shinji Itoh, Takahiro Tomiyama, Noboru Harada, Takeo Toshima, Yoshihiro Nagao, Norifumi Iseda, Takeshi Kurihara, Yoshinao Oda and Masaki Mori and has published in prestigious journals such as SHILAP Revista de lepidopterología, British journal of surgery and Cancer Science.

In The Last Decade

Akinari Morinaga

24 papers receiving 311 citations

Peers

Akinari Morinaga
Zili Hu China
Guo Long China
Jin Gu China
Wan Ling Tan Singapore
Yugo Kai Japan
Akinari Morinaga
Citations per year, relative to Akinari Morinaga Akinari Morinaga (= 1×) peers Norifumi Iseda

Countries citing papers authored by Akinari Morinaga

Since Specialization
Citations

This map shows the geographic impact of Akinari Morinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinari Morinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinari Morinaga more than expected).

Fields of papers citing papers by Akinari Morinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinari Morinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinari Morinaga. The network helps show where Akinari Morinaga may publish in the future.

Co-authorship network of co-authors of Akinari Morinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Akinari Morinaga. A scholar is included among the top collaborators of Akinari Morinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinari Morinaga. Akinari Morinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toshida, Katsuya, Shinji Itoh, Noboru Harada, et al.. (2022). Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma. Cancer Science. 114(3). 937–947. 12 indexed citations
3.
Tomiyama, Takahiro, Shinji Itoh, Katsuya Toshida, et al.. (2022). A rare case of unresectable, microsatellite instability-high hepatocellular carcinoma and an examination of the tumor microenvironment. International Cancer Conference Journal. 12(1). 81–86. 1 indexed citations
4.
Tomiyama, Takahiro, Noboru Harada, Takeo Toshima, et al.. (2022). Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study. Transplant International. 35. 10723–10723. 3 indexed citations
5.
Kurihara, Takeshi, Noboru Harada, Akinari Morinaga, et al.. (2022). Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant. Transplantation Proceedings. 55(1). 191–196. 1 indexed citations
6.
Toshima, Takeo, Noboru Harada, Shinji Itoh, et al.. (2022). Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan. Clinical Transplantation. 36(8). e14739–e14739. 7 indexed citations
7.
Tomiyama, Takahiro, Masahiro Shimokawa, Noboru Harada, et al.. (2022). Low syntaxin 17 expression in donor liver is associated with poor graft prognosis in recipients of living donor liver transplantation. Hepatology Research. 52(10). 872–881. 1 indexed citations
8.
Tomiyama, Takahiro, Shinji Itoh, Norifumi Iseda, et al.. (2022). Myeloid‑derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma. Oncology Letters. 23(3). 93–93. 18 indexed citations
9.
Shimagaki, Tomonari, Shinji Itoh, Katsuya Toshida, et al.. (2022). Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report. Journal of Surgical Case Reports. 2022(10). rjac479–rjac479. 2 indexed citations
10.
Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status. Hepatology Communications. 6(4). 665–678. 14 indexed citations
11.
Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. International Journal of Clinical Oncology. 26(10). 1890–1900. 35 indexed citations
12.
Tomiyama, Takahiro, Takashi Motomura, Norifumi Iseda, et al.. (2021). Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report. SHILAP Revista de lepidopterología. 7(1). 118–118. 1 indexed citations
13.
Inokuchi, Shoichi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma. Langenbeck s Archives of Surgery. 406(3). 773–779. 6 indexed citations
14.
Yugawa, Kyohei, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma. International Journal of Clinical Oncology. 26(10). 1901–1910. 15 indexed citations
15.
Itoh, Shinji, Tomoharu Yoshizumi, Takahiro Tomiyama, et al.. (2021). Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma. JGH Open. 5(7). 785–792. 5 indexed citations
16.
Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2020). ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma. Hepatology Communications. 5(4). 675–688. 19 indexed citations
17.
Kosai‐Fujimoto, Yukiko, Tomoharu Yoshizumi, Takahiro Tomiyama, et al.. (2020). Living-Donor Liver Transplantation for Patients With Extrahepatic Malignancy: A Series of 14 Patients in a Single Institution. Transplantation Proceedings. 52(3). 889–893. 3 indexed citations
18.
Yugawa, Kyohei, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2020). CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma. Hepatology Communications. 5(2). 334–348. 30 indexed citations
19.
Watanabe, Akira, Tomoharu Yoshizumi, Norifumi Harimoto, et al.. (2020). Right hepatic venous system variation in living donors: a three-dimensional CT analysis. British journal of surgery. 107(9). 1192–1198. 4 indexed citations
20.
Iseda, Norifumi, Tomoharu Yoshizumi, Takeo Toshima, et al.. (2018). Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature. SHILAP Revista de lepidopterología. 4(1). 101–101. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026